ARS PharmaceuticalsSPRY

那斯達克 · USD
3.69
+0.04
(+1.10%)
收盤 11/19 04:59 (UTC+8)
11/19 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.01
  • 0.02
  • 0.87
  • 0.08
  • 0.16
  • 0.33
  • 0.28
  • 0.23
  • 0.34
  • 0.38
icon
  • -
  • 313.60
  • 4086.70
  • -90.79
  • 97.13
  • 106.79
  • -13.58
  • -19.25
  • 48.40
  • 12.04
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q3
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
營業收入淨額
37,710
33,658
22,681
28,087
32,501
15,717
7,973
86,581
2,068
500
營業成本
10,09812,8466,2866,1548,1914,9841,094865112-
營業毛利
27,612
20,812
16,395
21,933
24,310
10,733
6,879
85,716
1,956
500
營業費用
61,78382,27776,54063,39877,50258,34744,05638,51923,70415,840
研發費用
18,2634,6984,3363,4432,7514,0352,9523,0274,4236,896
推銷及管理費用
43,52077,57972,20459,95574,75154,31241,10435,49219,2818,944
非經常性項目費用
----------
其他營業費用
----------
營業利益
-34,171
-61,465
-60,145
-41,465
-53,192
-47,614
-37,177
47,197
-21,748
-15,340
其他收入及費用
1,1361,6051,9682,6042,0412,7313,2373,0252,6202,824
利息費用
2,5522,4792,4412,543------
稅前純益
-35,587
-62,339
-60,618
-41,404
-51,151
-44,883
-33,940
50,222
-19,128
-12,516
所得稅
----80---288--
稅後純益
-35,587
-62,339
-60,618
-41,324
-51,151
-44,883
-33,940
49,934
-19,128
-12,516
基本每股稅後盈餘(元)
-0.36-0.63-0.61-0.41-0.52-0.46-0.35--0.20-0.13
稀釋每股稅後盈餘(元)
-0.35-0.63-0.61-0.42-0.52-0.45-0.350.51-0.19-0.13
基本平均股數(千股)
99685.0099312.0099296.0099037.0098807.0098361.0098060.00-97032.0096827.00
稀釋平均股數(千股)
99685.0099312.0099296.0099037.0098807.0098361.0098060.00-97032.0096827.00
還原基本每股稅後盈餘(元)
-0.36-0.63-0.61-0.41-0.52-0.46-0.35--0.20-0.13
還原稀釋每股稅後盈餘(元)
-0.35-0.63-0.61-0.42-0.52-0.45-0.350.51-0.19-0.13
還原基本平均股數(千股)
99,68599,31299,29699,03798,80798,36198,060-97,03296,827
還原稀釋平均股數(千股)
99,68599,31299,29699,03798,80798,36198,060-97,03296,827
EBITDA(千元)
-33,050-60,094-58,770-39,447-51,852-46,071-35,62148,707-20,933-14,402

大家都在看

HOT